These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 15148321)

  • 21. Two major Smad pathways in TGF-beta superfamily signalling.
    Miyazawa K; Shinozaki M; Hara T; Furuya T; Miyazono K
    Genes Cells; 2002 Dec; 7(12):1191-204. PubMed ID: 12485160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor-derived C-terminal mutations of Smad4 with decreased DNA binding activity and enhanced intramolecular interaction.
    Kuang C; Chen Y
    Oncogene; 2004 Feb; 23(5):1021-9. PubMed ID: 14647410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Smad6 recruits transcription corepressor CtBP to repress bone morphogenetic protein-induced transcription.
    Lin X; Liang YY; Sun B; Liang M; Shi Y; Brunicardi FC; Shi Y; Feng XH
    Mol Cell Biol; 2003 Dec; 23(24):9081-93. PubMed ID: 14645520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Zebrafish Smad7 is regulated by Smad3 and BMP signals.
    Pogoda HM; Meyer D
    Dev Dyn; 2002 Jul; 224(3):334-49. PubMed ID: 12112463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads.
    Itoh F; Asao H; Sugamura K; Heldin CH; ten Dijke P; Itoh S
    EMBO J; 2001 Aug; 20(15):4132-42. PubMed ID: 11483516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A nuclear antagonistic mechanism of inhibitory Smads in transforming growth factor-beta signaling.
    Bai S; Cao X
    J Biol Chem; 2002 Feb; 277(6):4176-82. PubMed ID: 11711531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular interpretation of multiple TGF-beta signals: intracellular antagonism between activin/BVg1 and BMP-2/4 signaling mediated by Smads.
    Candia AF; Watabe T; Hawley SH; Onichtchouk D; Zhang Y; Derynck R; Niehrs C; Cho KW
    Development; 1997 Nov; 124(22):4467-80. PubMed ID: 9409665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Degradation of the tumor suppressor Smad4 by WW and HECT domain ubiquitin ligases.
    Morén A; Imamura T; Miyazono K; Heldin CH; Moustakas A
    J Biol Chem; 2005 Jun; 280(23):22115-23. PubMed ID: 15817471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two short segments of Smad3 are important for specific interaction of Smad3 with c-Ski and SnoN.
    Mizuide M; Hara T; Furuya T; Takeda M; Kusanagi K; Inada Y; Mori M; Imamura T; Miyazawa K; Miyazono K
    J Biol Chem; 2003 Jan; 278(1):531-6. PubMed ID: 12426322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nuclear factor YY1 inhibits transforming growth factor beta- and bone morphogenetic protein-induced cell differentiation.
    Kurisaki K; Kurisaki A; Valcourt U; Terentiev AA; Pardali K; Ten Dijke P; Heldin CH; Ericsson J; Moustakas A
    Mol Cell Biol; 2003 Jul; 23(13):4494-510. PubMed ID: 12808092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Repression of bone morphogenetic protein and activin-inducible transcription by Evi-1.
    Alliston T; Ko TC; Cao Y; Liang YY; Feng XH; Chang C; Derynck R
    J Biol Chem; 2005 Jun; 280(25):24227-37. PubMed ID: 15849193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Smad7 Protein Interacts with Receptor-regulated Smads (R-Smads) to Inhibit Transforming Growth Factor-β (TGF-β)/Smad Signaling.
    Yan X; Liao H; Cheng M; Shi X; Lin X; Feng XH; Chen YG
    J Biol Chem; 2016 Jan; 291(1):382-92. PubMed ID: 26555259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tob proteins enhance inhibitory Smad-receptor interactions to repress BMP signaling.
    Yoshida Y; von Bubnoff A; Ikematsu N; Blitz IL; Tsuzuku JK; Yoshida EH; Umemori H; Miyazono K; Yamamoto T; Cho KW
    Mech Dev; 2003 May; 120(5):629-37. PubMed ID: 12782279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Negative regulation of transforming growth factor-beta (TGF-beta) signaling by WW domain-containing protein 1 (WWP1).
    Komuro A; Imamura T; Saitoh M; Yoshida Y; Yamori T; Miyazono K; Miyazawa K
    Oncogene; 2004 Sep; 23(41):6914-23. PubMed ID: 15221015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphorylation regulation of the interaction between Smad7 and activin type I receptor.
    Liu X; Nagarajan RP; Vale W; Chen Y
    FEBS Lett; 2002 May; 519(1-3):93-8. PubMed ID: 12023024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional conservation of Schistosoma mansoni Smads in TGF-beta signaling.
    Beall MJ; McGonigle S; Pearce EJ
    Mol Biochem Parasitol; 2000 Nov; 111(1):131-42. PubMed ID: 11087923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crystal structure of a phosphorylated Smad2. Recognition of phosphoserine by the MH2 domain and insights on Smad function in TGF-beta signaling.
    Wu JW; Hu M; Chai J; Seoane J; Huse M; Li C; Rigotti DJ; Kyin S; Muir TW; Fairman R; Massagué J; Shi Y
    Mol Cell; 2001 Dec; 8(6):1277-89. PubMed ID: 11779503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A component of the ARC/Mediator complex required for TGF beta/Nodal signalling.
    Kato Y; Habas R; Katsuyama Y; Näär AM; He X
    Nature; 2002 Aug; 418(6898):641-6. PubMed ID: 12167862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Smad7 inhibits transforming growth factor-beta family type i receptors through two distinct modes of interaction.
    Kamiya Y; Miyazono K; Miyazawa K
    J Biol Chem; 2010 Oct; 285(40):30804-13. PubMed ID: 20663871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TGF-beta signaling by Smad proteins.
    Miyazono K
    Cytokine Growth Factor Rev; 2000; 11(1-2):15-22. PubMed ID: 10708949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.